Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Apricot and Perilla Cough Syrup (Xingsu Zhike Tangjiang) is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Juneng Golden Key Pharmaceutical (Wuhan Juneng Jinshi Pharmaceutical). It is an approved oral liquid/syrup indicated for the symptomatic relief of cough and respiratory distress, particularly those associated with the common cold or wind-cold type coughs. The formulation typically utilizes a combination of herbal ingredients, including bitter apricot kernel (*Semen Armeniacae Amarum*) and perilla leaf (*Folium Perillae*), which are traditionally recognized in TCM for their ability to ventilate the lungs, disperse cold, and resolve phlegm. As a complex herbal mixture, it does not target a single molecular pathway but rather functions through the synergistic effects of its constituent phytochemicals to alleviate respiratory symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Apricot and Perilla Cough Syrup.